FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049658547> ?p ?o ?g. }

• W3049658547 endingPage "383" @default.
• W3049658547 startingPage "371" @default.
• W3049658547 abstract "Abstract Alcoholic liver disease (ALD) is associated with gut dysbiosis and hepatic inflammasome activation. While it is known that antimicrobial peptides (AMPs) play a critical role in the regulation of bacterial homeostasis in ALD, the functional role of AMPs in the alcohol‐induced inflammasome activation is unclear. The aim of this study was to determine the effects of cathelicidin‐related antimicrobial peptide (CRAMP) on inflammasome activation in ALD. CRAMP knockout ( Camp −/− ) and wild‐type (WT) mice were subjected to binge‐on‐chronic alcohol feeding and synthetic CRAMP peptide was administered. Serum/plasma and hepatic tissue samples from human subjects with alcohol use disorder and/or alcoholic hepatitis were analyzed. CRAMP deficiency exacerbated ALD with enhanced inflammasome activation as shown by elevated serum interleukin (IL)‐1β levels. Although Camp −/− mice had comparable serum endotoxin levels compared to WT mice after alcohol feeding, hepatic lipopolysaccharide (LPS) binding protein (LBP) and cluster of differentiation (CD) 14 were increased. Serum levels of uric acid (UA), a Signal 2 molecule in inflammasome activation, were positively correlated with serum levels of IL‐1β in alcohol use disorder patients with ALD and were increased in Camp −/− mice fed alcohol. In vitro studies showed that CRAMP peptide inhibited LPS binding to macrophages and inflammasome activation stimulated by a combination of LPS and UA. Synthetic CRAMP peptide administration decreased serum UA and IL‐1β concentrations and rescued the liver from alcohol‐induced damage in both WT and Camp −/− mice. In summary, CRAMP exhibited a protective role against binge‐on‐chronic alcohol‐induced liver damage via regulation of inflammasome activation by decreasing LPS binding and UA production. CRAMP administration may represent a novel strategy for treating ALD. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd." @default.
• W3049658547 created "2020-08-21" @default.
• W3049658547 creator A5005615491 @default.
• W3049658547 creator A5012100988 @default.
• W3049658547 creator A5020633342 @default.
• W3049658547 creator A5024084224 @default.
• W3049658547 creator A5024426792 @default.
• W3049658547 creator A5038901616 @default.
• W3049658547 creator A5057601894 @default.
• W3049658547 creator A5057633505 @default.
• W3049658547 creator A5060264631 @default.
• W3049658547 creator A5061880957 @default.
• W3049658547 creator A5064047182 @default.
• W3049658547 creator A5064564572 @default.
• W3049658547 creator A5067281481 @default.
• W3049658547 creator A5073638043 @default.
• W3049658547 creator A5074747020 @default.
• W3049658547 creator A5080536190 @default.
• W3049658547 date "2020-09-26" @default.
• W3049658547 modified "2023-10-18" @default.
• W3049658547 title "Cathelicidin‐related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation" @default.
• W3049658547 cites W1577996379 @default.
• W3049658547 cites W1583831774 @default.
• W3049658547 cites W1812571265 @default.
• W3049658547 cites W182694654 @default.
• W3049658547 cites W1861790843 @default.
• W3049658547 cites W1972181361 @default.
• W3049658547 cites W1975691929 @default.
• W3049658547 cites W1983778185 @default.
• W3049658547 cites W1985434991 @default.
• W3049658547 cites W2005008021 @default.
• W3049658547 cites W2012992997 @default.
• W3049658547 cites W2016057875 @default.
• W3049658547 cites W2027968599 @default.
• W3049658547 cites W2034801500 @default.
• W3049658547 cites W2053542703 @default.
• W3049658547 cites W2053661184 @default.
• W3049658547 cites W2058029859 @default.
• W3049658547 cites W2060637877 @default.
• W3049658547 cites W2076870635 @default.
• W3049658547 cites W2080195958 @default.
• W3049658547 cites W2083183071 @default.
• W3049658547 cites W2105482626 @default.
• W3049658547 cites W2114405620 @default.
• W3049658547 cites W2129438583 @default.
• W3049658547 cites W2136354950 @default.
• W3049658547 cites W2138986581 @default.
• W3049658547 cites W2159776927 @default.
• W3049658547 cites W2160397887 @default.
• W3049658547 cites W2165578318 @default.
• W3049658547 cites W2167927725 @default.
• W3049658547 cites W2222049260 @default.
• W3049658547 cites W2267180887 @default.
• W3049658547 cites W2392871520 @default.
• W3049658547 cites W2549253162 @default.
• W3049658547 cites W2613759337 @default.
• W3049658547 cites W2619680342 @default.
• W3049658547 cites W2786057901 @default.
• W3049658547 cites W2803013275 @default.
• W3049658547 cites W2804782408 @default.
• W3049658547 cites W2885459366 @default.
• W3049658547 cites W2900595525 @default.
• W3049658547 cites W2904855182 @default.
• W3049658547 cites W2944826126 @default.
• W3049658547 cites W2972832664 @default.
• W3049658547 cites W2992334955 @default.
• W3049658547 cites W970934513 @default.
• W3049658547 doi "https://doi.org/10.1002/path.5531" @default.
• W3049658547 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8006217" @default.
• W3049658547 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33245573" @default.
• W3049658547 hasPublicationYear "2020" @default.
• W3049658547 type Work @default.
• W3049658547 sameAs 3049658547 @default.
• W3049658547 citedByCount "16" @default.
• W3049658547 countsByYear W30496585472021 @default.
• W3049658547 countsByYear W30496585472022 @default.
• W3049658547 countsByYear W30496585472023 @default.
• W3049658547 crossrefType "journal-article" @default.
• W3049658547 hasAuthorship W3049658547A5005615491 @default.
• W3049658547 hasAuthorship W3049658547A5012100988 @default.
• W3049658547 hasAuthorship W3049658547A5020633342 @default.
• W3049658547 hasAuthorship W3049658547A5024084224 @default.
• W3049658547 hasAuthorship W3049658547A5024426792 @default.
• W3049658547 hasAuthorship W3049658547A5038901616 @default.
• W3049658547 hasAuthorship W3049658547A5057601894 @default.
• W3049658547 hasAuthorship W3049658547A5057633505 @default.
• W3049658547 hasAuthorship W3049658547A5060264631 @default.
• W3049658547 hasAuthorship W3049658547A5061880957 @default.
• W3049658547 hasAuthorship W3049658547A5064047182 @default.
• W3049658547 hasAuthorship W3049658547A5064564572 @default.
• W3049658547 hasAuthorship W3049658547A5067281481 @default.
• W3049658547 hasAuthorship W3049658547A5073638043 @default.
• W3049658547 hasAuthorship W3049658547A5074747020 @default.
• W3049658547 hasAuthorship W3049658547A5080536190 @default.
• W3049658547 hasBestOaLocation W30496585472 @default.
• W3049658547 hasConcept C126322002 @default.
• W3049658547 hasConcept C134018914 @default.
• W3049658547 hasConcept C185592680 @default.

• next